Pages

Friday, October 25, 2019

Novartis takes $80M punt on early-stage NASH drug from Pliant - - pharmaphorum

Novartis takes $80M punt on early-stage NASH drug from Pliant -  pharmaphorum
Novartis takes $80M punt on early-stage NASH drug from Pliant - - pharmaphorum
Read More
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)